Global Ligases Enzyme Market Set to Grow to $5.64 Billion by 2029, High Albany Reported Growth in Personalized Medicine and Synthetic Biology

 

The ligases enzyme market size has grown rapidly in recent years. It is expected to grow from $3.23 billion in 2024 to $3.58 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to the initial discovery and development of ligase enzymes, growth of the biotechnology industry, increased understanding of DNA repair mechanisms, expansion of genetic engineering applications, and rise in demand for molecular diagnostics. It is predicted to grow rapidly to reach $5.64 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%, growth driven by the expansion of personalized medicine applications, growing focus on synthetic biology, adoption of ligase enzymes in drug development, increased demand for molecular diagnostics, and integration of ligases in next-generation sequencing.

Get Your Free Sample of The Global Ligases Enzyme Global Market Report 2024 Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12226&type=smp

What Factors Are Propelling The Ligases Enzyme Market Growth?
The increasing prevalence of cancer and genetic disorders is driving the growth of the ligase’s enzyme market. With the rise in these medical conditions, there is a subsequent increase in the demand for ligases enzyme for DNA replication, repair, and recombination. For instance, Australia has seen a notable rise in cancer cases, from 160,570 in 2022 to 164,694 in 2023. Similarly, in the UK, around 1 in 25 children are affected by a genetic condition, leading to more than 2.4 million children and adults living with a genetic disorder.

What Are The Major Segments In The Ligases Enzyme Market?
1) By Type: E. coli DNA ligase, T4 DNA Ligase, Mammalian Ligases, Thermostable Ligases
2) By Source: Microorganisms, Animal, Plant
3) By Application: Ligase Chain Reaction (LCR), Ligase Detection Reaction (LDR), Next-Generation Sequencing (NGS), Repeat Expansion Detection (RED), Rolling Circle Amplification (RCA), Proximity Ligation Assay (PLA), Molecular Cloning, Ligation Mediated PCR, Mutation Detection
4) By End-User: Research Laboratories And Institutions, Pharmaceutical And Biopharmaceutical Companies, Diagnostic Laboratories

Order your report now for swift delivery:
https://www.thebusinessresearchcompany.com/report/ligases-enzyme-global-market-report

Which Leading Companies Are Operating In The Ligases Enzyme Market?
Notable companies operating in the ligases enzyme market include BASF SE, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., GenScript, Promega Corporation, Oxford Nanopore Technologies Limited, Takara Bio Inc., New England Biolabs Inc., BioVision Inc., Enzo Life Sciences, Zymo Research, LGC Biosearch Technologies, Genetix Biotech Asia Pvt. Ltd., BLIRT S.A., Jena Bioscience, Bioline, Creative Enzymes, ArcticZymes Technologies ASA.

What Trends Are Emerging In the Ligases Enzyme Market?
There is an increasing trend of developing technologies such as nanopore technologies to enhance the precision and efficiency of DNA sequencing and manipulation, improving applications in genomics, synthetic biology, and personalized medicine. For instance, in February 2023, Eurofins Genomics launched the Express Oxford Nanopore Sequencing service, allowing for the sequencing of long DNA fragments, beneficial for comprehensive genomic analysis.

Which Region is Leading in the Ligases Enzyme Market?
In 2024, North America was the largest region in the ligases enzyme market, with Asia-Pacific expected to be the fastest-growing region during the forecast period.

What Does The Ligases Enzyme Global Market Report 2024 Report 2025 Offer?
Ligase enzymes refer to a class of proteins that catalyze the joining of two DNA strands, essential in various cellular processes, including DNA replication and protein synthesis. The Ligases Enzyme Global Market Report 2024 research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12226

About The Business Research Company
The Business Research Company, with over 15,000 reports from 27 industries covering 60+ geographies, has built a reputation for offering comprehensive, data-rich research and insights. With 1,500,000 datasets, the valuable contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Comments

Post a Comment

Popular posts from this blog

Global Antiepileptic Drugs Market Forecast Highlights Growth Outlook And Key Trends Over 2026–2030

Image
  The antiepileptic drugs market size has grown strongly in recent years. It will grow from $17.83 billion in 2025 to $18.74 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to epilepsy prevalence growth, first-generation drug reliance, hospital neurology expansion, seizure disorder awareness, generic drug penetration. The antiepileptic drugs market size is expected to see strong growth in the next few years. It will grow to $22.87 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to treatment-resistant epilepsy management, novel AED approvals, personalized neurology care, pediatric epilepsy diagnosis, long-acting formulations. Major trends in the forecast period include shift toward third-generation AEDs, growing use of combination therapy, expansion of pediatric epilepsy management, increased adoption of long-term seizure control, growth of gene...
Read more

Global Haptic Virtual Reality (VR) Fitness Suit Market Analysis Highlights Emerging Opportunities And Revenue Forecasts Through 2030

Image
  The haptic virtual reality (vr) fitness suit market size has grown exponentially in recent years. It will grow from $1.6 billion in 2025 to $2.05 billion in 2026 at a compound annual growth rate (CAGR) of 27.7%. The growth in the historic period can be attributed to rising popularity of virtual fitness applications, increasing consumer interest in immersive workouts, growth of wearable fitness technologies, expansion of home-based fitness solutions, improvements in haptic hardware capabilities. The haptic virtual reality (vr) fitness suit market size is expected to see exponential growth in the next few years. It will grow to $5.4 billion in 2030 at a compound annual growth rate (CAGR) of 27.4%. The growth in the forecast period can be attributed to increasing adoption of ai-driven fitness personalization, rising demand for remote and virtual training solutions, expansion of rehabilitation and therapeutic vr applications, growing integration of biometric feedback systems, advan...
Read more

2025 Strategic Guide to the Drugs For Benign Prostatic hypertrophy Market – Forecasts and Business Use Cases

Image
  The drugs for benign prostatic hypertrophy market size has grown strongly in recent years. It will grow from $4.28 billion in 2024 to $4.58 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to aging population, increased awareness, advancements in drug therapies, healthcare access. The drugs for benign prostatic hypertrophy market size is expected to see strong growth in the next few years. It will grow to $5.58 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to emerging markets, new drug developments, increasing awareness and education, regulatory approvals. Major trends in the forecast period include minimally invasive treatments, personalized medicine, combination therapies, patient-centered care, telemedicine and digital health, research and development. #Download Your Free Sample PDF:# https://www.thebusinessresearchcompany.com/sample.a...
Read more